Similar articles for PMID: 26795288

Year	Number of Results
1998	1
2004	3
2005	5
2006	3
2007	7
2008	2
2009	6
2010	8
2011	7
2012	16
2013	14
2014	14
2015	14
2016	20
2017	16
2018	20
2019	13
2020	14
2021	13
2022	15
2023	2
2024	0

1

The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer.

van Rossum PS, Fried DV, Zhang L, Hofstetter WL, van Vulpen M, Meijer GJ, Court LE, Lin SH. van Rossum PS, et al. J Nucl Med. 2016 May;57(5):691-700. doi: 10.2967/jnumed.115.163766. Epub 2016 Jan 21. J Nucl Med. 2016. PMID: 26795288 Free article.

2

Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging ¹⁸F-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer.

Beukinga RJ, Hulshoff JB, Mul VEM, Noordzij W, Kats-Ugurlu G, Slart RHJA, Plukker JTM. Beukinga RJ, et al. Radiology. 2018 Jun;287(3):983-992. doi: 10.1148/radiol.2018172229. Epub 2018 Mar 14. Radiology. 2018. PMID: 29533721

3

Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patients.

Kim SJ, Koo PJ, Chang S. Kim SJ, et al. Cancer Chemother Pharmacol. 2016 Apr;77(4):723-31. doi: 10.1007/s00280-016-2988-8. Epub 2016 Feb 18. Cancer Chemother Pharmacol. 2016. PMID: 26891957

4

The value of ¹⁸F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma.

van Rossum PSN, Fried DV, Zhang L, Hofstetter WL, Ho L, Meijer GJ, Carter BW, Court LE, Lin SH. van Rossum PSN, et al. Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):71-80. doi: 10.1007/s00259-016-3478-2. Epub 2016 Aug 11. Eur J Nucl Med Mol Imaging. 2017. PMID: 27511188 Free PMC article.

5

¹⁸F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.

Xi M, Liao Z, Hofstetter WL, Komaki R, Ho L, Lin SH. Xi M, et al. J Nucl Med. 2017 Nov;58(11):1756-1763. doi: 10.2967/jnumed.117.192591. Epub 2017 May 18. J Nucl Med. 2017. PMID: 28522744 Free PMC article.

6

Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment ¹⁸F-FDG PET/CT Imaging.

Beukinga RJ, Hulshoff JB, van Dijk LV, Muijs CT, Burgerhof JGM, Kats-Ugurlu G, Slart RHJA, Slump CH, Mul VEM, Plukker JTM. Beukinga RJ, et al. J Nucl Med. 2017 May;58(5):723-729. doi: 10.2967/jnumed.116.180299. Epub 2016 Oct 13. J Nucl Med. 2017. PMID: 27738011 Free article.

7

Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using ¹⁸F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study.

Borggreve AS, Goense L, van Rossum PSN, Heethuis SE, van Hillegersberg R, Lagendijk JJW, Lam MGEH, van Lier ALHMW, Mook S, Ruurda JP, van Vulpen M, Voncken FEM, Aleman BMP, Bartels-Rutten A, Ma J, Fang P, Musall BC, Lin SH, Meijer GJ. Borggreve AS, et al. Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):998-1009. doi: 10.1016/j.ijrobp.2019.12.038. Epub 2020 Jan 25. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987972 Free PMC article. Clinical Trial.

8

Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.

Kukar M, Alnaji RM, Jabi F, Platz TA, Attwood K, Nava H, Ben-David K, Mattson D, Salerno K, Malhotra U, Kanehira K, Gannon J, Hochwald SN. Kukar M, et al. JAMA Surg. 2015 Jun;150(6):555-62. doi: 10.1001/jamasurg.2014.3867. JAMA Surg. 2015. PMID: 25902198

9

Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma.

Purandare NC, Pramesh CS, Karimundackal G, Jiwnani S, Agrawal A, Shah S, Kulkarni M, Laskar SG, Rangarajan V. Purandare NC, et al. Nucl Med Commun. 2014 Aug;35(8):864-9. doi: 10.1097/MNM.0000000000000137. Nucl Med Commun. 2014. PMID: 24751701

10

Utility of ¹⁸F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation.

Arnett ALH, Merrell KW, Macintosh EM, James SE, Nathan MA, Shen KR, Ravi K, Neben Wittich MA, Haddock MG, Hallemeier CL. Arnett ALH, et al. J Thorac Oncol. 2017 Jan;12(1):121-128. doi: 10.1016/j.jtho.2016.08.136. Epub 2016 Aug 26. J Thorac Oncol. 2017. PMID: 27569732 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

185 results

Results by year